Potential Role of Musashi-2 RNA-Binding Protein in Cancer EMT.
Jian SunWeiwei ShengYuteng MaMing DongPublished in: OncoTargets and therapy (2021)
Local invasion and distant metastasis are the key hallmarks in the aggressive progression of malignant tumors, including the ability of cancer cells to detach from the extracellular matrix overcome apoptosis, and disseminate into distant sites. It is generally believed that this malignant behavior is stimulated by epithelial-mesenchymal transition (EMT). Musashi (MSI) RNA-binding proteins, belonging to the evolutionarily conserved RNA-binding proteins (RBP) family, were originally discovered to regulate asymmetric cell division during embryonic development. Recently, Musashi-2 (MSI2), as a key member of MSI family, has been prevalently reported to be tightly associated with the advanced clinical stage of several cancers. Multiple oncogenic signaling pathways mediated by MSI2 play vital roles in EMT. Here, we systematically reviewed the detailed role and signal networks of MSI2 in regulating cancer development, especially in EMT signal transduction, involving EGF, TGF-β, Notch, and Wnt pathways.
Keyphrases
- epithelial mesenchymal transition
- transforming growth factor
- signaling pathway
- extracellular matrix
- papillary thyroid
- binding protein
- squamous cell
- lymph node
- transcription factor
- cell proliferation
- stem cells
- endoplasmic reticulum stress
- single cell
- childhood cancer
- cell death
- mesenchymal stem cells
- pi k akt
- induced apoptosis
- growth factor
- bone marrow
- young adults
- cell migration